CVAC
CureVac NV
NASDAQ: CVAC · HEALTHCARE · BIOTECHNOLOGY
$4.66
+0.00% today
Updated 2026-04-30
Market cap
$1.05B
P/E ratio
6.96
P/S ratio
14.83x
EPS (TTM)
$0.67
Dividend yield
—
52W range
$3 – $6
Volume
1.1M
CureVac NV (CVAC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$4.66
12-Month target
$5.78
2030 Target
—
Intrinsic (DCF)
$13.95
Financial forecast
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.1B | $0.1B | $0.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 6.96x (capped 25x) · Margin: 182.10%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.